Seventh International Symposium on Myelodysplastic Syndromes
Int J Hematol
.
2003 Oct;78(3):272-5.
doi: 10.1007/BF02983809.
Author
Yataro Yoshida
1
Affiliation
1
Takeda General Hospital, Kyoto, Japan. yoshida@takedahp.or.jp
PMID:
14604291
DOI:
10.1007/BF02983809
No abstract available
Publication types
Congress
MeSH terms
Antineoplastic Agents / therapeutic use
Hematopoietic Stem Cell Transplantation
Humans
Mutation
Myelodysplastic Syndromes* / diagnosis
Myelodysplastic Syndromes* / etiology
Myelodysplastic Syndromes* / therapy
Substances
Antineoplastic Agents